Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trials
about
Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.The role of surfactant in respiratory distress syndromeGestational exposure of mice to secondhand cigarette smoke causes bronchopulmonary dysplasia blocked by the nicotinic receptor antagonist mecamylamineClinical effects of pulmonary surfactant in combination with nasal continuous positive airway pressure therapy on neonatal respiratory distress syndrome.
P2860
Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trials
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Animal-derived surfactants for ...... me: summary of clinical trials
@en
Animal-derived surfactants for ...... e: summary of clinical trials.
@nl
type
label
Animal-derived surfactants for ...... me: summary of clinical trials
@en
Animal-derived surfactants for ...... e: summary of clinical trials.
@nl
prefLabel
Animal-derived surfactants for ...... me: summary of clinical trials
@en
Animal-derived surfactants for ...... e: summary of clinical trials.
@nl
P2860
P356
P1476
Animal-derived surfactants for ...... me: summary of clinical trials
@en
P2093
Fernando R Moya
J Wells Logan
P2860
P304
P356
10.2147/TCRM.S4029
P577
2009-02-01T00:00:00Z